Susanne Schmitt
Holzkirchen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Using Machine Learning for the Fusion of Tumor Records on a Real-World Dataset.
Journal: Studies in health technology and informatics
Published: May 17, 2025
Implementation of the Anchor-Based Indirect Comparison Method for Equivalence Margin Derivation in Biosimilar Development.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 19, 2024
Comparison of Imputation Methods for Categorical Real-World Prostate Cancer Data with Natural Order.
Comparison of Imputation Methods for Categorical Real-World Prostate Cancer Data with Natural Order.
Journal: Studies in health technology and informatics
Published: August 23, 2024
Trial Probability of Success for Testing 3-Way PK/PD Similarity With Multiple Endpoints.
Journal: Pharmaceutical statistics
Published: August 06, 2024
A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy.
Journal: Arthritis research & therapy
Published: December 29, 2017
Evaluation of the safety and immunogenicity of subcutaneous HX575 epoetin alfa in the treatment of anemia associated with chronic kidney disease in predialysis and dialysis patients .
Journal: Clinical nephrology
Published: August 03, 2017
A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease.
Journal: American journal of nephrology
Published: July 27, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026